scispace - formally typeset
I

Ing Shian Soon

Researcher at University of Calgary

Publications -  13
Citations -  4368

Ing Shian Soon is an academic researcher from University of Calgary. The author has contributed to research in topics: Inflammatory bowel disease & Colectomy. The author has an hindex of 6, co-authored 12 publications receiving 3786 citations.

Papers
More filters
Journal ArticleDOI

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

TL;DR: Although there are few epidemiologic data from developing countries, the incidence and prevalence of IBD are increasing with time and in different regions around the world, indicating its emergence as a global disease.
Journal ArticleDOI

The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis

TL;DR: A positive association between urban environment and both CD and UC was found and associations persisted across multiple stratified and sensitivity analyses exploring clinical and study quality factors.
Journal ArticleDOI

Postoperative complications following colectomy for ulcerative colitis in children.

TL;DR: Colectomy UC was uncommon and rates have remained stable and postcolectomy complications were common, especially in patients undergoing emergent colectomy, which suggests optimizing timing of colectomies may reduce postoperative complications.
Journal ArticleDOI

Nationwide temporal trends in incidence of hospitalization and surgical intestinal resection in pediatric inflammatory bowel diseases in the United States from 1997 to 2009.

TL;DR: The annual incidence of hospitalization is climbing in pediatric inflammatory bowel diseases, accompanied by rising intestinal resection rates for CD and stable colectomy rates for UC.
Journal ArticleDOI

Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease

TL;DR: Children with IBD, including a large proportion on immunosuppressive medications, have low seropositivity to CMV and EBV, in spite of high vaccine coverage and universal vaccinations.